Abstract
The transmission of bloodborne viruses through transfusion remains a major blood supply–related safety concern, with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) being the most important pathogens in this context. Real-time bioluminescent pyrophosphate testing has been developed as a means of readily detecting bacterial cells within particular sample types without requiring the use of expensive or complex instrumentation. The sensitivity of this approach, however, is often limited such that it is not compatible with many potential applications. In this study, we sought to overcome the limitations of this pyrophosphate bioluminescent assay format by using 2-deoxyadenosine-5-(α-thio)-triphosphate (dATPαS) in place of dATP for PCR amplification, thereby dramatically reducing background signal levels. We leveraged this combination PCR and bioluminescent pyrophosphate assay approach to facilitate HBV detection. This assay yielded a limit of detection of 500 copies/mL, making it more sensitive than traditional bioluminescent assays, about 1000 times more sensitive than that of PCR product analysis by agarose gel electrophoresis, and roughly as sensitive as qPCR as a means of detecting viral DNA. We then used this assay to analyze 100 serum samples, with qPCR being used for result validation. The assay required 100 min to complete, and was able to detect as few as 500 copies/mL of viral DNA. Overall, our approach was rapid, sensitive, and simple, enabling users to readily detect HBV in a reliable and efficient manner.
Similar content being viewed by others
Data availability
The data used or analyzed during the current study are available from the corresponding author on reasonable request.
References
Kamimura, H., Watanabe, J., Sugano, T., Kohisa, J., Abe, H., Kamimura, K., Tsuchiya, A., Takamura, M., Okoshi, S., Tanabe, Y., Takagi, R., Nonaka, H., & Terai, S. (2021). Relationship between detection of hepatitis B virus in saliva and periodontal disease in hepatitis B virus carriers in Japan. Journal of infection and chemotherapy, 27, 492–496.
Arıkan, A., Sayan, M., & Doluca, O. (2020). NeuMoDx random access molecular diagnostic system for detection and quantification of hepatitis B virus in clinical samples. The Journal of Infection in Developing Countries, 14, 1197–1203.
Wang, H., Wang, M., Huang, J., Xu, R., Liao, Q., Shan, Z., Zheng, Y., Rong, X., Tang, X., Li, T., Wang, W., Li, C., & Fu, Y. (2020). Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. Journal of viral hepatitis, 27, 915–921.
Sanou, A. M., Toyé, R., Kagoné, T., Nikiéma, A., Testa, J., Sakandé, J., Sangaré, L., Tarnagda, Z., Kania, D. (2020). Analytical performance of eight rapid point-of-care tests routinely used for the detection of HBsAg in Burkina Faso: A cross-sectional study. Journal of clinical virology, 129https://doi.org/10.1016/j.jcv.2020.104546
Mohsin, D., Mashkour, M., & Fatemi, F. (2020). Design of aptamer-based sensing platform using gold nanoparticles functionalized reduced graphene oxide for ultrasensitive detection of Hepatitis B virus. Chemical Papers, 75, 279–295. https://doi.org/10.1007/s11696-020-01292-1
Shariati, M., & Sadeghi, M. (2020). Ultrasensitive DNA biosensor for hepatitis B virus detection based on tin-doped WO(3)/In(2)O(3) heterojunction nanowire photoelectrode under laser amplification. Analytical and bioanalytical chemistry, 412, 5367–5377.
Teng, C. F., Li, T. C., Huang, H. Y., Lin, J. H., Chen, W. S., Shyu, W. C., Wu, H. C., Peng, C. Y., Su, I. J., & Jeng, L. B. (2020). Next-generation sequencing-based quantitative detection of hepatitis B virus pre-S mutants in plasma predicts hepatocellular carcinoma recurrence. Viruses, 12, 796. https://doi.org/10.3390/v1280796
Phung, T. T. B., Chu, S. V., Vu, S. T., Pham, H. T., Nguyen, H. M., Nguyen, H. D., Le, N. T., Nguyen, D. V., Truong, P. T., Vu, V. T. T., & Nguyen, A. T. V. (2020). COLD-PCR method for early detection of antiviral drug-resistance mutations in treatment-naive children with chronic hepatitis B. Diagnostics (Basel), 10, 491. https://doi.org/10.3390/diagnostics10070491
Dembele, B., Affi-Aboli, R., Kabran, M., Sevede, D., Goha, V., Adiko, A. C., Kouamé, R., Allah-Kouadio, E., Inwoley, A. (2020). Evaluation of four rapid tests for detection of hepatitis B surface antigen in ivory coast. Journal of immunology research, 6315718https://doi.org/10.1155/2020/631578
Deshpande, A., Dunn, A. N., Fox, J., Cadnum, J. L., Mana, T. S. C., Jencson, A., Fraser, T. G., Donskey, C. J., & Gordon, S. M. (2020). Monitoring the effectiveness of daily cleaning practices in an intensive care unit (ICU) setting using an adenosine triphosphate (ATP) bioluminescence assay. American journal of infection control, 48, 757–760.
Srisomwat, C., Teengam, P., Chuaypen, N., Tangkijvanich, P., Vilaivan, T., & Chailapakul, O. (2020). Pop-up paper electrochemical device for label-free hepatitis B virus DNA detection. Sensors and Actuators B: Chemical, 316, 128077. https://doi.org/10.1016/j.snb.2020.128077
Brunetto, M. R. (2020). Hepatitis B virus RNA detection and a mindful use of serum hepatitis B virus DNA and hepatitis B surface antigen measures in clinical practice. Hepatology Communications, 4, 949–952. https://doi.org/10.1002/hep4.1554
Teng, C. F., Tsai, H. W., Li, T. C., Wang, T., Wang, J., Shyu, W. C., Wu, H. C., Su, I. J., & Jeng, L. B. (2020). Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues. PLoS ONE, 15, e0234773. https://doi.org/10.1371/journal.pone.0234773
Konijeti, G. G., Grandhe, S., Tincopa, M., Lane, J. A., Shrime, M. G., Singh, S., & Loomba, R. (2020). Cost-effectiveness analysis of screening for hepatitis B virus infection in patients with solid tumors before initiating chemotherapy. Clinical gastroenterology and hepatology, 18, 1600–1608. https://doi.org/10.1016/j.cgh.2019.10.039
Zhang, J., Wang, D., Zou, L., Xiao, M., Zhang, Y., Li, Z., Yang, L., Ge, G., & Zuo, Z. (2020). Rapid bioluminescence assay for monitoring rat CES1 activity and its alteration by traditional Chinese medicines. Journal of pharmaceutical analysis, 10, 253–262.
Imamura, O., Arakawa, H., & Maeda, M. (2003). Simple and rapid bioluminescent detection of two verotoxin genes using allele-specific PCR of E. coli O157: H7. Luminescence, 18, 107–112.
Ronaghi, M., Karamohamed, S., Pettersson, B., Uhlén, M., & Nyrén, P. (1996). Real-time DNA sequencing using detection of pyrophosphate release. Analytical biochemistry, 242, 84–89.
Arakawa, H., Karasawa, K., Igarashi, T., Suzuki, S., Goto, N., & Maeda, M. (2004). Detection of cariogenic bacteria genes by a combination of allele-specific polymerase chain reactions and a novel bioluminescent pyrophosphate assay. Analytical biochemistry, 333, 296–302.
Kajiyama, T., Kuwahara, M., Goto, M., & Kambara, H. (2011). Optimization of pyrosequencing reads by superior successive incorporation efficiency of improved 2′-deoxyadenosine-5′-triphosphate analogs. Analytical biochemistry, 416, 8–17.
Xu, Q., Huang, S. Q., Ma, F., Tang, B., & Zhang, C. Y. (2016). Controllable mismatched ligation for bioluminescence screening of known and unknown mutations. Analytical Chemistry, 88, 2413–2419. https://doi.org/10.1021/acs.analchem.5b04540
Xu, Q., Zhu, G., & Zhang, C. Y. (2013). Homogeneous bioluminescence detection of biomolecules using target-triggered hybridization chain reaction-mediated ligation without luciferase label. Analytical Chemistry, 85, 6915–6921.
Funding
This work was funded by the National Natural Science Foundation of China, grant numbers 61971123 and 61571114, and Jiangsu Commission of Health, grant number LGY2020015.
Author information
Authors and Affiliations
Contributions
Conceptualization, methodology, software, data curation, writing—original draft preparation: GT, ZF, RW, PX, and XW. Visualization, investigation, validation: GT and ZF. Supervision, project administration, funding acquisition, and writing: PX and XW.
Corresponding authors
Ethics declarations
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Consent to Publish
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Guolei Tan, Zhongjie Fei and Rongbin Wei contributed equally
Rights and permissions
About this article
Cite this article
Tan, G., Fei, Z., Wei, R. et al. Development of a Novel Bioluminescence Pyrophosphate Assay for the High-Sensitivity Detection of Hepatitis B Virus. Appl Biochem Biotechnol 194, 725–736 (2022). https://doi.org/10.1007/s12010-021-03655-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-021-03655-0